Suchergebnisse - "Pinato, David J"

PubPharm (285)

81

Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Takada, K. | Buti, S. | Bersanelli, M. | +13

82

T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma

enthalten in: Journal of hepatology | 2022

von Barsch, M. | Salié, H. | Schlaak, A. | +30

83

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Pinato, D. | Ferrante, D. | Aguilar-Company, J. | +149

84

Outcome of liver cancer patients with SARS-CoV-2 infection : An International, Multicentre, Cohort Study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Muñoz-Martínez, S. | Sapena, V. | Forner, A. | +52

85

COVID-19 Sequelae and the Host Proinflammatory Response : An Analysis From the OnCovid Registry

enthalten in: Journal of the National Cancer Institute | 2022

von Cortellini, A. | Gennari, A. | Pommeret, F. | +100

86

Persistence of long-term COVID-19 sequelae in patients with cancer : An analysis from the OnCovid registry

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Cortellini, A. | Salazar, R. | Gennari, A. | +32

87

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study

enthalten in: The Lancet. Oncology | 2022

von Pinato, D. | Aguilar-Company, J. | Ferrante, D. | +147

88

Breaking the Child-Pugh Dogma in Hepatocellular Carcinoma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Johnson, P. | Pinato, D. | Kalyuzhnyy, A. | +1

89

Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma : evaluation of safety and efficacy in a retrospective, propensity score-matched study

enthalten in: Journal for immunotherapy of cancer | 2022

von Marinelli, B. | Kim, E. | D'Alessio, A. | +23

90

Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC : The Backbone Matters

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Cortellini, A. | Facchinetti, F. | Derosa, L. | +1

CommentOn: J Thorac Oncol. 2022 Jun;17(6):758-767. - PMID 35183773